Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Therapy for Ulcerative Colitis
NCT03986996Phase 2Terminated
- Sponsor
- Edith Wolfson Medical Center
- Start
- Jul 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of amoxicillin and doxycycline in ulcerative colitis (UC) (2 arms), sponsored by Edith Wolfson Medical Center. Primary endpoint: Clinical Response in group 1 and 2 or Clinical Remission at Week 3. Started Jul 2019; status: terminated.
02
Drugs
amoxicillindoxycycline
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03986996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03986996.